6-Bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one
- $240 - $328
- Product name: 6-Bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one
- CAS: 1393845-82-3
- MF: C11H12BrN3O
- MW: 282.14
- EINECS:
- MDL Number:MFCD22383941
- Synonyms:2H-Imidazo[4,5-b]pyridin-2-one, 6-bromo-1-cyclopentyl-1,3-dihydro-
4 prices
Selected condition:
Brand
- Matrix Scientific
- SynQuest Laboratories
Package
- 500mg
- 1g
- ManufacturerMatrix Scientific
- Product number077004
- Product description6-Bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one 97%
- Packaging1g
- Price$328
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number077004
- Product description6-Bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one 97%
- Packaging500mg
- Price$262
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number4H53-9-06
- Product description6-Bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one
- Packaging500mg
- Price$240
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number4H53-9-06
- Product description6-Bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one
- Packaging1g
- Price$320
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Matrix Scientific | 077004 | 6-Bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one 97% | 1g | $328 | 2021-12-16 | Buy |
Matrix Scientific | 077004 | 6-Bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one 97% | 500mg | $262 | 2021-12-16 | Buy |
SynQuest Laboratories | 4H53-9-06 | 6-Bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one | 500mg | $240 | 2021-12-16 | Buy |
SynQuest Laboratories | 4H53-9-06 | 6-Bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one | 1g | $320 | 2021-12-16 | Buy |
Properties
Density :1.622±0.06 g/cm3(Predicted)
pka :11.31±0.20(Predicted)
pka :11.31±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|